Your browser doesn't support javascript.
loading
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.
Millot, Frédéric; Dupraz, Christelle; Guilhot, Joelle; Suttorp, Meinolf; Brizard, Françoise; Leblanc, Thierry; Günes, Adalet Meral; Sedlacek, Petr; De Bont, Evelyne; Li, Chi Kong; Kalwak, Krzysztof; Lausen, Birgitte; Culic, Srdjana; Dworzak, Michael; Kaiserova, Emilia; De Moerloose, Barbara; Roula, Farah; Biondi, Andrea; Baruchel, André; Guilhot, François.
Afiliação
  • Millot F; INSERM Clinical Investigation Center 1402, Poitiers University, Poitiers, France.
  • Dupraz C; INSERM Clinical Investigation Center 1402, Poitiers University, Poitiers, France.
  • Guilhot J; INSERM Clinical Investigation Center 1402, Poitiers University, Poitiers, France.
  • Suttorp M; Department of Pediatrics, Carl Gustav Carus University Hospital, Dresden, Germany.
  • Brizard F; INSERM Clinical Investigation Center 1402, Poitiers University, Poitiers, France.
  • Leblanc T; Department of Pediatric Hematology, Robert Debré Hospital, Paris, France.
  • Günes AM; Department of Pediatric Hematology, Uludag University Hospital, Görükle Bursa, Turkey.
  • Sedlacek P; Department of Pediatric Hematology-Oncology, Motol University Hospital, Charles University, Prague, Czech Republic.
  • De Bont E; Department of Pediatric Oncology-Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Li CK; Dutch Childhood Oncology Group, the Hague, the Netherlands.
  • Kalwak K; Department of Pediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China.
  • Lausen B; Department of Pediatric Hematology-Oncology and Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Culic S; Department of Pediatrics, Rigshospitalet, University Hospital, Copenhagen, Denmark.
  • Dworzak M; Department of Pediatric Hematology, Oncology, Immunology, and Medical Genetics, Clinical Hospital, Split, Croatia.
  • Kaiserova E; Children's Cancer Research Institute and St. Anna Children's Hospital, Vienna, Austria.
  • De Moerloose B; Department of Pediatric Oncology, University Children's Hospital, Bratislava, Slovakia.
  • Roula F; Department of Pediatrics, Ghent University Hospital, Ghent, Belgium.
  • Biondi A; Department of Pediatrics, Saint George Hospital University Medical Centre, Beirut, Lebanon.
  • Baruchel A; Department of Pediatrics, San Gerardo Hospital, University of Milano-Bicocca, Fondazione Monza e Brianza per il Bambino e la sua Mamma, Monza, Italy.
  • Guilhot F; Department of Pediatric Hematology, Robert Debré Hospital, Paris, France.
Cancer ; 123(18): 3609-3616, 2017 Sep 15.
Article em En | MEDLINE | ID: mdl-28497898

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 9 / Cromossomos Humanos Par 22 / Leucemia Mielogênica Crônica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Aberrações Cromossômicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 9 / Cromossomos Humanos Par 22 / Leucemia Mielogênica Crônica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Aberrações Cromossômicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França